Philip D Harvey

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Genome Wide Association

Bipolar Disorder

Top Venues

Translational psychiatry

medRxiv : the preprint server for health sciences

Neuropsychopharmacology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Philip D Harvey, Courtney Dowell-Esquivel, Justin E Macchiarelli, Alejandro Martinez, Peter Kallestrup, Sara J Czaja
Early prediction of mastery of a computerized functional skills training program in participants with mild cognitive impairment. International psychogeriatrics (2024)
Allison Elizabeth Ashley-Koch, Nathan A Kimbrel, Xue-Jun Qin, Jennifer H Lindquist, Melanie E Garrett, Michelle F Dennis, Lauren P Hair, Jennifer E Huffman, Daniel A Jacobson, Ravi K Madduri, Hilary Coon, Anna R Docherty, Jooeun Kang, Niamh Mullins, Douglas M Ruderfer, null null, null null, null null, Philip D Harvey, Benjamin H McMahon, David W Oslin, Elizabeth R Hauser, Michael A Hauser, Jean C Beckham
Genome-wide association study identifies four pan-ancestry loci for suicidal ideation in the Million Veterans Program. PLoS genetics 19 (3) (2023)
Sara E Jones, Philip D Harvey
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system. Translational psychiatry 13 (1) (2023)
Sara E Jones, Philip D Harvey
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system. Translational psychiatry 13 (1) (2023)
Peter B Barr, Tim B Bigdeli, Jacquelyn M Meyers, Roseann E Peterson, Sandra Sanchez-Roige, Travis T Mallard, Danielle M Dick, Kathryn Paige Harden, Anna Wilkinson, David P Graham, David A Nielsen, Alan Swann, Rachele K Lipsky, Thomas R Kosten, Mihaela Aslan, null null, null null, Philip D Harvey, Nathan A Kimbrel, Jean C Beckham
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort. medRxiv : the preprint server for health sciences (2023)
Sara E Jones, Philip D Harvey
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system. Translational psychiatry 13 (1) (2023)
Tim B Bigdeli, Peter B Barr, Nallakkandi Rajeevan, David P Graham, Yuli Li, Jacquelyn M Meyers, Bryan R Gorman, Roseann E Peterson, Frederick Sayward, Krishnan Radhakrishnan, Sundar Natarajan, David A Nielsen, Anna V Wilkinson, Anil K Malhotra, Hongyu Zhao, Mary Brophy, Yunling Shi, Timothy J Oâ Leary, Theresa Gleason, Ronald Przygodzki, Saiju Pyarajan, Sumitra Muralidhar, John Michael Gaziano, null null, null null, Grant D Huang, John Concato, Larry J Siever, Lynn E DeLisi, Nathan A Kimbrel, Jean C Beckham, Alan C Swann, Thomas R Kosten, Ayman H Fanous, Mihaela Aslan, Philip D Harvey
Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. medRxiv : the preprint server for health sciences (2023)
Raeanne Cristine Moore, Colin Andrew Depp, Philip D Harvey, Amy E Pinkham
Assessing the Real-Time Mental Health Challenges of COVID-19 in Individuals With Serious Mental Illnesses: Protocol for a Quantitative Study. JMIR research protocols 9 (5) (2020)
Philip D Harvey, Hiroshi Nakamura, Sadanori Miura
Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study. Neuropsychopharmacology reports 40 (1) (2019)
Martin T Strassnig, Vanessa Nascimento, Elizabeth Deckler, Philip D Harvey
Pharmacological treatment of violence in schizophrenia. CNS spectrums 25 (2) (2019)
Mackenzie T Jones, Philip D Harvey
Neurocognition and social cognition training as treatments for violence and aggression in people with severe mental illness. CNS spectrums 25 (2) (2019)
Juliet Silberstein, Philip D Harvey
Cognition, social cognition, and Self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes. CNS spectrums 24 (1) (2019)
Philip D Harvey, Hiroshi Nakamura, Mitsukuni Murasaki
Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled study. Neuropsychopharmacology reports 39 (3) (2019)
Philip D Harvey, Ning Sun, Tim B Bigdeli, Ayman H Fanous, Mihaela Aslan, Anil K Malhotra, Qiongshi Lu, Yiming Hu, Boyang Li, Quan Chen, Shrikant Mane, Perry Miller, Nallakkandi Rajeevan, Frederick Sayward, Kei-Hoi Cheung, Yuli Li, Tiffany A Greenwood, Raquel C Gur, David L Braff, null null, Mary Brophy, Saiju Pyarajan, Timothy J O'Leary, Theresa Gleason, Ronald Przygodszki, Sumitra Muralidhar, J Michael Gaziano, John Concato, Hongyu Zhao, Larry J Siever
Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 183 (3) (2019)